Reynolds Delgado III, MD

Dr. Reynolds M. Delgado, III is a cardiologist specializing in heart failure and heart transplantation at Baylor St. Luke’s Medical Center/The Texas Heart Institute. He has been a Basic Science Researcher in Heart Failure at The Texas Heart Institute, Baylor College of Medicine, and The University of Texas Houston Medical School since 1997 and has held the position of Medical Director of Mechanical Support Devices in Heart Failure at The Texas Heart Institute since 2003. His academic appointments include clinical assistant professor of medicine at Baylor College of Medicine and UT Health Science Center, Houston. He participates on numerous advisory boards, including Thoratec Corporation, Medtronic Corporation and Boston Scientific Corporation, and has been on the Medical Education Committee at The Texas Heart Institute since 2004. He is also a long-standing research collaborator with NASA Johnson Space Center Human Space Flight Physiology Laboratory.

Show full bio

Dr. Delgado earned a Bachelor of Arts from The University of Texas at Austin in 1987, and a medical degree from The University of Texas Southwestern Medical School in Dallas in 1991. He completed a residency in internal medicine at The University of Texas Southwestern Medical School, and a fellowship in cardiology at The University of Texas Houston Health Science Center. Included in that fellowship program was a 15-month fellowship in heart failure and clinical cardiac transplantation at The Texas Heart Institute.

He created the heart failure clinic program at Baylor St. Luke’s Medical Center and is on the Transplant Medical Review Board there. As a result of his extensive experience in the heart failure and transplant arenas, he was one of four physicians worldwide asked to develop the Guidelines for the Care of Heart Transplant Recipients by the International Society for Heart and Lung Transplantation. He also authored “Mechanical Circulatory Support in Patients with Heart Failure,” included in the definitive textbook Health Failure: A Companion to Braunwald’s Heart Disease.

Dr. Delgado has authored or co-authored numerous articles for major scientific journals, including the New England Journal of Medicine, the Journal of Heart and Lung Transplantation, Congestive Heart Failure, and Circulation, the premier journal of the American Heart Association. He currently serves or has served on the editorial boards of The Texas Heart Institute Journal, Circulation, and the Journal of Heart and Lung Transplantation. He lectures extensively, with presentations in Mexico, Canada, Greece, France, Serbia, Slovenia, and Argentina, among other places.

See Publications

Texas Heart Institute Positions

Current Projects

Interests

  • Cardiology
  • Heart Failure

Education

  • Undergraduate:

    The University of Texas (Biology)

  • Medical School:

    The University of Texas Southwestern Medical School

  • Residency:

    The University of Texas Southwestern - Parkland Health & Hospital System

  • Fellowships:

    The University of Texas Health Science Center - Houston
    The Texas Heart Institute, Heart Failure and Cardiac Transplantation

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center

Certifications

  • American Board of Internal Medicine
  • Advanced Heart Failure/Transplant Cardiology

Honors, Awards and Memberships

Publications

4862227 TIPQ3BD5 1 alternatives-to-animal-experimentation 10 date desc Delgado 1884 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KIK8DC32%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chou%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChou%2C%20B.%20P.%2C%20Critsinelis%2C%20A.%2C%20Lamba%2C%20H.%20K.%20et%20al.%20%282021%29.%20Continuous-flow%20left%20ventricular%20assist%20device%20support%20in%20patients%20with%20ischemic%20versus%20nonischemic%20cardiomyopathy.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20e207241.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7241%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7241%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Continuous-flow%20left%20ventricular%20assist%20device%20support%20in%20patients%20with%20ischemic%20versus%20nonischemic%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brendan%20P.%22%2C%22lastName%22%3A%22Chou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Long%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22To%20determine%20whether%20the%20cause%20of%20cardiomyopathy%20affects%20outcomes%20in%20patients%20who%20undergo%20continuous-flow%20left%20ventricular%20assist%20device%20support%2C%20we%20compared%20postimplant%20adverse%20events%20and%20survival%20between%20patients%20with%20ischemic%20and%20nonischemic%20cardiomyopathy.%20The%20inclusion%20criteria%20for%20the%20ischemic%20group%20were%20a%20history%20of%20myocardial%20infarction%20or%20revascularization%20%28coronary%20artery%20bypass%20grafting%20or%20percutaneous%20coronary%20intervention%29%2C%20%5Cu226575%25%20stenosis%20of%20the%20left%20main%20or%20proximal%20left%20anterior%20descending%20coronary%20artery%2C%20or%20%5Cu226575%25%20stenosis%20of%20%5Cu22652%20epicardial%20vessels.%20From%20November%202003%20through%20March%202016%2C%20526%20patients%20underwent%20device%20support%3A%20256%20%2848.7%25%29%20in%20the%20ischemic%20group%20and%20270%20%2851.3%25%29%20in%20the%20nonischemic%20group.%20The%20ischemic%20group%20was%20older%20%2860.0%20vs%2050.0%20yr%29%2C%20included%20more%20men%20than%20women%20%2884.0%25%20vs%2072.6%25%29%2C%20and%20had%20more%20comorbidities.%20More%20patients%20in%20the%20nonischemic%20group%20were%20able%20to%20have%20their%20devices%20explanted%20after%20left%20ventricular%20recovery%20%285.9%25%20vs%202.0%25%3B%20P%3D0.02%29.%20More%20patients%20in%20the%20ischemic%20group%20had%20gastrointestinal%20bleeding%20%2831.2%25%20vs%2022.6%25%3B%20P%3D0.03%29%2C%20particularly%20from%20arteriovenous%20malformations%20%2820.7%25%20vs%2011.9%25%3B%20P%3D0.006%29%20and%20ulcers%20%2816.4%25%20vs%209.3%25%3B%20P%3D0.01%29.%20Kaplan-Meier%20analysis%20revealed%20no%20difference%20in%20overall%20survival%20between%20groups%20%28P%3D0.24%29.%20Older%20age%2C%20previous%20sternotomy%2C%20higher%20total%20bilirubin%20level%2C%20and%20concomitant%20procedures%20during%20device%20implantation%20independently%20predicted%20death%20%28P%20%5Cu22640.03%29%2C%20whereas%20cause%20of%20heart%20failure%20did%20not%20%28P%3D0.08%29.%20Despite%20the%20similarity%20in%20overall%20survival%20between%20groups%2C%20ischemic%20cardiomyopathy%20was%20associated%20with%20more%20frequent%20gastrointestinal%20bleeding.%20This%20information%20may%20help%20guide%20the%20care%20of%20patients%20with%20ischemic%20cardiomyopathy%20who%20receive%20continuous-flow%20left%20ventricular%20assist%20device%20support.%22%2C%22date%22%3A%22Sept%2001%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-20-7241%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22VCK5HVUS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A04%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22TMA8G96M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parikh%20et%20al.%22%2C%22parsedDate%22%3A%222020-11%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParikh%2C%20V.%20Y.%2C%20Parikh%2C%20U.%20M.%2C%20Moctezuma-Ramirez%2C%20A.%20et%20al.%20%282020%29.%20Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BGen%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B68%26lt%3B%5C%2Fi%26gt%3B%2C%201278%26%23x2013%3B1284.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20Y.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Umang%20M.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Moctezuma-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Savitri%22%2C%22lastName%22%3A%22Fedson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Warfarin%20is%20standard%20anticoagulation%20therapy%20for%20patients%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29.%20However%2C%20warfarin%20requires%20regular%20monitoring%20and%20dosage%20adjustments%20and%20fails%20for%20many%20patients%2C%20causing%20thromboembolic%20and%20bleeding%20events.%20Factor%20Xa%20inhibitors%20have%20been%20shown%20to%20be%20noninferior%20to%20warfarin%20in%20preventing%20strokes%20and%20are%20associated%20with%20less%20intracranial%20hemorrhage%20in%20patients%20with%20atrial%20fibrillation.%20We%20evaluated%20treatment%20safety%20and%20effectiveness%20in%20CF-LVAD%20patients%20who%20switched%20from%20warfarin%20to%20a%20factor%20Xa%20inhibitor%20%28apixaban%20or%20rivaroxaban%29%20after%20warfarin%20failure.%5CnMETHODS%3A%20This%20was%20a%20retrospective%2C%20single-center%20study%20of%20patients%20treated%20between%202008%20and%202018.%20We%20assessed%20the%20occurrence%20of%20stroke%2C%20non-central%20nervous%20system%20%28CNS%29%20embolism%2C%20pump%20thrombosis%2C%20and%20major%20gastrointestinal%20bleeding%20and%20intracranial%20hemorrhage%20during%20therapy.%5CnRESULTS%3A%20We%20identified%20seven%20patients%3A%20five%20were%20male%2C%20the%20average%20body%20mass%20index%20was%2030%5Cu00a0kg%5C%2Fm2%2C%20and%20average%20age%20was%2056%5Cu00a0years.%20Preimplantation%20comorbidities%20included%20hypertension%20%28all%20patients%29%20and%20diabetes%20mellitus%2C%20ischemic%20cardiomyopathy%2C%20atrial%20fibrillation%2C%20and%20previous%20myocardial%20infarction%20%28four%5Cu00a0patients%20each%29.%20Overall%2C%20patients%20received%20warfarin%20for%203968%5Cu00a0days%20and%20apixaban%5C%2Frivaroxaban%20for%201459%5Cu00a0days.%20The%20warfarin%20group%20was%20within%20the%20therapeutic%20INR%20range%20%282.0-3.0%29%2030%25%20of%20the%20time.%20Complication%20rates%20did%20not%20differ%20between%20warfarin%20and%20apixaban%5C%2Frivaroxaban%3A%20strokes%2C%200.20%20vs%20none%2C%20non-CNS%20embolism%2C%200.54%20vs%20none%3B%20pump%20thrombosis%2C%200.27%20vs%20none%3B%20major%20gastrointestinal%20bleeding%2C%200.20%20vs%200.50%3B%20intracranial%20hemorrhage%2C%200.13%20vs%20none.%5CnCONCLUSIONS%3A%20Factor%20Xa%20inhibitors%20may%20be%20viable%20treatment%20options%20for%20CF-LVAD%20patients%20for%20whom%20warfarin%20therapy%20has%20failed.%20Large%20prospective%20studies%20are%20necessary%20to%20confirm%20these%20results.%22%2C%22date%22%3A%22Nov%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11748-020-01371-w%22%2C%22ISSN%22%3A%221863-6713%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22TIPQ3BD5%22%2C%22S7WF6DG3%22%2C%2264GCVCDC%22%2C%22WS63FIXU%22%2C%22QZHY2RIG%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22FNHSY2JN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letsou%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLetsou%2C%20G.%20V.%2C%20Musfee%2C%20F.%20I.%2C%20Lee%2C%20A.%20D.%20et%20al.%20%282020%29.%20Ten-year%20survival%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20and%20aortic%20valve%20closure.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%20325%26%23x2013%3B328.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-19-7193%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-19-7193%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ten-year%20survival%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20and%20aortic%20valve%20closure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Letsou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadi%20I.%22%2C%22lastName%22%3A%22Musfee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20long-term%20survival%20of%20a%2046-year-old%20man%20supported%20with%20a%20HeartMate%20II%20continuous-flow%20left%20ventricular%20assist%20device%20after%20complex%20repair%20of%20a%20bicuspid%20aortic%20valve%2C%20anomalous%20left%20main%20coronary%20artery%2C%20and%20dilated%20aorta.%20He%20has%20been%20maintained%20on%20an%20anticoagulation%20regimen%20of%20warfarin%20and%20low-dose%20aspirin%20without%20problems%20for%2010%20years%2C%20during%20which%20he%20has%20worked%20continuously%20and%20productively.%20Device%20flow%20has%20been%20kept%20at%2010%2C000%20rpm.%20Possible%20contributors%20to%20this%20long-term%20success%20include%20proper%20alignment%20of%20the%20device%20inflow%20cannula%2C%20pericardial%20patch%20closure%20of%20the%20left%20ventricular%20outflow%20tract%2C%20and%2C%20notably%2C%20the%20remarkable%20freedom%20from%20mechanical%20failure%20of%20the%20continuous-flow%20left%20ventricular%20assist%20device.%20Whether%20the%20higher%20flow%20rate%20produced%20by%20the%20pericardial%20patch%20closure%20contributes%20to%20pump%20longevity%20is%20unknown%20and%20merits%20further%20investigation.%22%2C%22date%22%3A%22Aug%201%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-19-7193%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22TIPQ3BD5%22%2C%22YZAQAZIS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A40Z%22%7D%7D%2C%7B%22key%22%3A%223IBSAC2U%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maffei%20et%20al.%22%2C%22parsedDate%22%3A%222020-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaffei%2C%20S.%20R.%2C%20Lamba%2C%20H.%20K.%2C%20Mensah%2C%20C.%20K.%20et%20al.%20%282020%29.%20Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B109%26lt%3B%5C%2Fi%26gt%3B%2C%20e439%26%23x2013%3Be440.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvador%20R.%22%2C%22lastName%22%3A%22Maffei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassius%20Kwasi%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Bracey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Anticoagulation%20with%20unfractionated%20heparin%20is%20vital%20to%20reduce%20the%20risk%20of%20thromboembolic%20events%20during%20cardiopulmonary%20bypass%20and%20left%20ventricular%20assist%20device%20placement.%20However%20patients%20with%20heparin-induced%20thrombocytopenia%20are%20at%20risk%20of%20developing%20immune-mediated%20thrombotic%20events.%20We%20describe%202%20patients%20with%20heparin-induced%20thrombocytopenia%20confirmed%20via%20serotonin%20release%20assay%20who%20were%20successfully%20treated%20with%20plasmapheresis%20exchange%20before%20left%20ventricular%20assist%20device%20placement.%22%2C%22date%22%3A%22Jun%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2019.09.056%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22KIXH6H5E%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A29Z%22%7D%7D%2C%7B%22key%22%3A%227G69KG9E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Critsinelis%20et%20al.%22%2C%22parsedDate%22%3A%222020-05%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCritsinelis%2C%20A.%20C.%2C%20Lamba%2C%20H.%20K.%2C%20Nguyen%2C%20M.%20T.%20et%20al.%20%282020%29.%20Accuracy%20of%20postoperative%20risk%20scores%20for%20survival%20prediction%20in%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20Profile%201%20continuous-flow%20left%20ventricular%20assist%20device%20recipients.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B66%26lt%3B%5C%2Fi%26gt%3B%2C%20539%26%23x2013%3B546.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001044%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001044%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20postoperative%20risk%20scores%20for%20survival%20prediction%20in%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20Profile%201%20continuous-flow%20left%20ventricular%20assist%20device%20recipients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%20C.%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20T.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20R.%22%2C%22lastName%22%3A%22Conroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%20H.%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selby%20B.%22%2C%22lastName%22%3A%22Oberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20study%2C%20we%20sought%20to%20determine%20the%20accuracy%20of%20several%20critical%20care%20risk%20scores%20for%20predicting%20survival%20of%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20%28INTERMACS%29%20Profile%201%20patients%20after%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29%20placement.%20We%20retrospectively%20analyzed%20the%20records%20of%20605%20patients%20who%20underwent%20CF-LVAD%20implantation%20between%202003%20and%202016.%20We%20calculated%20the%20preoperative%20HeartMate%20II%20Risk%20Score%20%28HMRS%29%20and%20preoperative%20Right%20Ventricular%20Failure%20Risk%20Score%20%28RVFRS%29%20and%20the%20following%20risk%20scores%20for%20postoperative%20days%201-5%3A%20HMRS%2C%20RVFRS%2C%20Model%20for%20End-stage%20Liver%20Disease%20%28MELD%29%2C%20MELD-eXcluding%20International%20Normalized%20Ratio%2C%20Post%20Cardiac%20Surgery%20%28POCAS%29%20risk%20score%2C%20Sequential%20Organ%20Failure%20Assessment%20%28SOFA%29%20risk%20score%2C%20and%20Acute%20Physiology%20and%20Chronic%20Health%20Evaluation%20III.%20The%20preoperative%20scores%20and%20the%20postoperative%20day%201%2C%205-day%20mean%2C%20and%205-day%20maximum%20scores%20were%20entered%20into%20a%20receiver%20operating%20characteristic%20curve%20analysis%20to%20examine%20accuracy%20for%20predicting%2030-day%2C%2090-day%2C%20and%201-year%20survival.%20The%20mean%20POCAS%20score%20was%20the%20best%20predictor%20of%2030-day%20and%2090-day%20survival%20%28area%20under%20the%20curve%20%5BAUC%5D%20%3D%200.869%20and%200.816%29.%20The%20postoperative%20mean%20RVFRS%20was%20the%20best%20predictor%20of%201-year%20survival%20%28AUC%20%3D%200.7908%29.%20The%20postoperative%20maximum%20and%20mean%20RVFRS%20and%20HMRS%20were%20more%20accurate%20than%20the%20preoperative%20scores.%20Both%20of%20these%20risk%20score%20measurements%20of%20acuity%20in%20the%20postoperative%20intensive%20care%20unit%20setting%20help%20predict%20early%20mortality%20after%20LVAD%20implantation.%22%2C%22date%22%3A%22May%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000001044%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22BCTBZ4XB%22%2C%22949A4W5I%22%2C%22VCK5HVUS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A04%3A18Z%22%7D%7D%2C%7B%22key%22%3A%224JTPRX5F%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chou%20et%20al.%22%2C%22parsedDate%22%3A%222020-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChou%2C%20B.%20P.%2C%20Lamba%2C%20H.%20K.%2C%20Cheema%2C%20F.%20H.%20et%20al.%20%282020%29.%20Outcomes%20of%20repeat%20left%20ventricular%20assist%20device%20exchange.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B66%26lt%3B%5C%2Fi%26gt%3B%2C%2064%26%23x2013%3B68.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000000928%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000000928%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20of%20repeat%20left%20ventricular%20assist%20device%20exchange%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brendan%20P.%22%2C%22lastName%22%3A%22Chou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%20H.%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selby%22%2C%22lastName%22%3A%22Oberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziad%20A.%22%2C%22lastName%22%3A%22Taimeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Implantable%20continuous-flow%20left%20ventricular%20assist%20devices%20%28CF-LVADs%29%20are%20used%20for%20long-term%20LV%20support%20in%20bridging%20patients%20to%20heart%20transplantation%20or%20as%20destination%20therapy.%20With%20prolonged%20support%20times%2C%20some%20patients%20will%20have%20repeat%20complications%20necessitating%20multiple%20device%20exchanges.%20To%20elucidate%20the%20safety%20and%20efficacy%20of%20repeat%20device%20exchange%2C%20we%20retrospectively%20reviewed%20data%20from%2025%20patients%20who%20underwent%20two%20or%20more%20CF-LVAD%20implantations%20between%20July%202005%20and%20August%202017.%20Indications%20for%20exchange%20were%20thrombus%5C%2Fhemolysis%20%28n%20%3D%208%2C%2032%25%29%2C%20electromechanical%20device%20malfunction%20%28n%20%3D%2014%2C%2056%25%29%2C%20and%20infection%20%28n%20%3D%203%2C%2012%25%29.%20The%20implanted%20devices%20were%20the%20HeartMate%20II%20%28n%20%3D%2013%2C%2052%25%29%2C%20the%20HeartWare%20HVAD%20%28n%20%3D%2011%2C%2044%25%29%2C%20and%20the%20Jarvik%202000%20%28n%20%3D%201%2C%204%25%29.%20Average%20hospital%20length%20of%20stay%20was%2044%20days%20%28range%204-221%20days%29%2C%20and%2017%20patients%20%2868%25%29%20survived%20to%20discharge.%20Average%20duration%20of%20support%20after%20the%20most%20recent%20LVAD%20implantation%20was%20802%20days%20%28range%201-3%2C229%20days%29.%20Overall%20survival%20was%2072%25%20at%201%20year%20and%2060%25%20at%202%20years.%20Postoperative%20complications%20included%20respiratory%20failure%20in%20five%20patients%20%2820%25%29%2C%20device%20infection%20in%20five%20%2820%25%29%2C%20bleeding%20requiring%20reoperation%20in%20four%20%2816%25%29%2C%20neurologic%20dysfunction%20in%20four%20%2816%25%29%2C%20and%20acute%20renal%20failure%20in%20two%20%288%25%29.%20Overall%2C%20our%20data%20suggest%20that%20repeat%20LVAD%20exchange%20is%20a%20feasible%20option%20for%20patients%20with%20recurrent%20device-related%20complications.%22%2C%22date%22%3A%22Jan%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000000928%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22BCTBZ4XB%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%2C%22949A4W5I%22%2C%2222K3TRJD%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22KG3ILPM3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hinds%20et%20al.%22%2C%22parsedDate%22%3A%222019-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHinds%2C%20E.%20D.%2C%20Marin%2C%20M.%20J.%2C%20George%2C%20J.%20et%20al.%20%282019%29.%20A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization.%20%26lt%3Bi%26gt%3BJRSM%20Cardiovasc%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%202048004019856801.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20D.%22%2C%22lastName%22%3A%22Hinds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%20J.%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22A%2056-year-old%20man%20who%20had%20twice%20previously%20undergone%20orthotopic%20heart%20transplantation%20was%20admitted%20with%20dyspnea%20and%20heart%20failure%20symptoms.%20A%20biopsy%20excluded%20rejection.%20Left%20heart%20catheterization%20revealed%20a%20coronary%20cameral%20fistula.%20After%20the%20patient%20was%20given%20mild%20diuretics%2C%20his%20condition%20improved.%20No%20significant%20fistula%20flow%20was%20detected%2C%20and%20he%20was%20discharged.%20Several%20months%20later%2C%20the%20patient%20was%20readmitted%20with%20worsening%20chest%20pain%20and%20dyspnea.%20Left%20ventricular%20end-diastolic%20pressure%20and%20flow%20through%20the%20fistula%20were%20increased.%20To%20correct%20the%20coronary%20cameral%20fistula%2C%20we%20performed%20a%20coil%20embolization%20without%20complications.%20Several%20months%20later%20at%20follow-up%2C%20the%20patient%26%23039%3Bs%20symptoms%20had%20resolved%2C%20and%20his%20left%20ventricular%20end-diastolic%20pressure%20had%20normalized.%20We%20conclude%20that%20coronary%20fistulas%20may%20be%20caused%20by%20trauma%20to%20the%20heart%20during%20the%20de-airing%20process%2C%20which%20may%20be%20prevented%20in%20the%20future%20with%20the%20development%20of%20safer%20and%20more%20effective%20de-airing%20techniques.%22%2C%22date%22%3A%222019%20Jan-Dec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F2048004019856801%22%2C%22ISSN%22%3A%222048-0040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22TIPQ3BD5%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22HQI7PV4E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anjum%20et%20al.%22%2C%22parsedDate%22%3A%222018-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAnjum%2C%20A.%2C%20Kurihara%2C%20C.%2C%20Critsinelis%2C%20A.%20et%20al.%20%282018%29.%20Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices.%20%26lt%3Bi%26gt%3BJ%20Artif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20285%26%23x2013%3B292.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azeen%22%2C%22lastName%22%3A%22Anjum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chitaru%22%2C%22lastName%22%3A%22Kurihara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masashi%22%2C%22lastName%22%3A%22Kawabori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tadahisa%22%2C%22lastName%22%3A%22Sugiura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Whitson%20B.%22%2C%22lastName%22%3A%22Etheridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Continuous-flow%20left%20ventricular%20assist%20devices%20%28CF-LVADs%29%20are%20increasingly%20being%20used%20to%20treat%20advanced%2C%20refractory%20chronic%20heart%20failure.%20Herein%2C%20we%20sought%20to%20determine%20the%20incidence%20of%20postoperative%20acute%20kidney%20injury%20%28AKI%29%20in%20axial-flow%20%28HeartMate%20II%3B%20HM-II%29%20and%20centrifugal-flow%20%28HVAD%29%20CF-LVAD%20recipients%2C%20as%20well%20as%20the%20effect%20of%20AKI%20on%20mortality.%20The%20study%20cohort%20comprised%20520%20patients%20who%20received%20a%20HM-II%20%28n%5Cu2009%3D%5Cu2009398%29%20or%20HVAD%20%28n%5Cu2009%3D%5Cu2009122%29%20at%20our%20center%20between%20November%202003%20and%20March%202016.%20Their%20records%20were%20reviewed%20to%20determine%20the%20incidence%20of%20RIFLE-defined%20AKI%20after%20LVAD%20implantation.%20We%20compared%20the%20perioperative%20characteristics%2C%20postoperative%20complications%2C%20and%20survival%20rates%20of%20the%20patients%20with%20and%20without%20AKI%20and%20differentiated%20the%20outcomes%20based%20on%20device%20type%20%28HM-II%20or%20HVAD%29.%20Seventy-five%20patients%20%2814.4%25%29%20developed%20AKI%20postoperatively.%20Patients%20with%20AKI%20after%20LVAD%20implantation%20had%20significantly%20reduced%20survival%20compared%20to%20patients%20without%20AKI%20%28p%5Cu2009%3D%5Cu20090.01%29.%20Cox%20proportional%20hazards%20models%20showed%20that%20AKI%20was%20a%20significant%20independent%20predictor%20of%20mortality%20%28HR%5Cu2009%3D%5Cu20091.54%2C%20p%5Cu2009%3D%5Cu20090.03%29.%20Preoperative%20mechanical%20circulatory%20support%20and%20prolonged%20cardiopulmonary%20bypass%20time%20were%20independent%20predictors%20of%20AKI.%20The%20incidence%20of%20AKI%20was%20similar%20for%20HM-II%20and%20HVAD%20recipients%20%28p%5Cu2009%3D%5Cu20090.25%29.%20There%20was%20no%20significant%20difference%20in%20AKI%20rates%20for%20the%20HM-II%20and%20HVAD%20recipients.%20Developing%20AKI%20adversely%20affected%20survival.%22%2C%22date%22%3A%22Sep%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10047-018-1047-0%22%2C%22ISSN%22%3A%221619-0904%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22YQCNXVUF%22%2C%22AAQ89W3S%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22QZ7NF7GX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gohar%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGohar%2C%20S.%2C%20Sheth%2C%20S.%20and%20%26lt%3Bstrong%26gt%3BDelgado%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%2C%20III%20%282017%29.%20Optimization%20of%20right%20ventricular%20function%20preoperatively%20for%20LVAD%20implantation.%20In%20%26lt%3Bi%26gt%3BMechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%3A%20A%20Texas%20Heart%20Institute%5C%2FBaylor%20College%20of%20Medicine%20Approach%26lt%3B%5C%2Fi%26gt%3B%20%2835%26%23x2013%3B55%29.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-319-65364-8_3.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Optimization%20of%20right%20ventricular%20function%20preoperatively%20for%20LVAD%20implantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Gohar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Sheth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%2C%20III%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Mechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%3A%20A%20Texas%20Heart%20Institute%5C%2FBaylor%20College%20of%20Medicine%20Approach%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22TIPQ3BD5%22%5D%2C%22dateModified%22%3A%222019-01-03T15%3A36%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22G8FJJEMX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jabbar%20et%20al.%22%2C%22parsedDate%22%3A%222015-02%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJabbar%2C%20A.%20A.%2C%20Franklin%2C%20W.%20J.%2C%20Simpson%2C%20L.%20et%20al.%20%282015%29.%20Improved%20systemic%20saturation%20after%20ventricular%20assist%20device%20implantation%20in%20a%20patient%20with%20decompensated%20dextro-transposition%20of%20the%20great%20arteries%20after%20the%20Fontan%20procedure.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B42%26lt%3B%5C%2Fi%26gt%3B%2C%2040%26%23x2013%3B43.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-13-3374%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-13-3374%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improved%20systemic%20saturation%20after%20ventricular%20assist%20device%20implantation%20in%20a%20patient%20with%20decompensated%20dextro-transposition%20of%20the%20great%20arteries%20after%20the%20Fontan%20procedure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20Abdul%22%2C%22lastName%22%3A%22Jabbar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wayne%20J.%22%2C%22lastName%22%3A%22Franklin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20successful%20implantation%20of%20a%20HeartMate%20II%20left%20ventricular%20assist%20device%20after%20a%20failed%20Fontan%20procedure%20in%20a%20patient%20with%20dextro-transposition%20of%20the%20great%20arteries.%20The%20patient%20had%20developed%20significant%20intrapulmonary%20arteriovenous%20shunting.%20Despite%20the%20theoretical%20risk%20of%20worsening%20intrapulmonary%20shunting%20due%20to%20the%20decrease%20in%20systemic%20vascular%20resistance%20after%20device%20implantation%2C%20our%20patient%20did%20well.%20He%20was%20discharged%20from%20the%20hospital%20in%20stable%20condition%20and%20had%20better%20oxygen%20saturation%20than%20before%20the%20device%20was%20implanted.%20To%20our%20knowledge%2C%20ours%20is%20the%202nd%20report%20of%20the%20use%20of%20a%20ventricular%20assist%20device%20after%20the%20failure%20of%20a%20Fontan%20procedure%2C%20and%20the%20first%20report%20concerning%20the%20effect%20of%20ventricular%20assist%20device%20implantation%20on%20intrapulmonary%20shunting.%22%2C%22date%22%3A%22Feb%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-13-3374%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22GW95W9I8%22%2C%22AAQ89W3S%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A19Z%22%7D%7D%5D%7D
Chou, B. P., Critsinelis, A., Lamba, H. K. et al. (2021). Continuous-flow left ventricular assist device support in patients with ischemic versus nonischemic cardiomyopathy. Tex Heart Inst J 48, e207241. https://doi.org/10.14503/THIJ-20-7241.
Parikh, V. Y., Parikh, U. M., Moctezuma-Ramirez, A. et al. (2020). Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg 68, 1278–1284. https://doi.org/10.1007/s11748-020-01371-w.
Letsou, G. V., Musfee, F. I., Lee, A. D. et al. (2020). Ten-year survival with a continuous-flow left ventricular assist device and aortic valve closure. Tex Heart Inst J 47, 325–328. https://doi.org/10.14503/THIJ-19-7193.
Maffei, S. R., Lamba, H. K., Mensah, C. K. et al. (2020). Plasmapheresis in patients with heparin-induced thrombocytopenia requiring ventricular assist device. Ann Thorac Surg 109, e439–e440. https://doi.org/10.1016/j.athoracsur.2019.09.056.
Critsinelis, A. C., Lamba, H. K., Nguyen, M. T. et al. (2020). Accuracy of postoperative risk scores for survival prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 continuous-flow left ventricular assist device recipients. ASAIO J 66, 539–546. https://doi.org/10.1097/MAT.0000000000001044.
Chou, B. P., Lamba, H. K., Cheema, F. H. et al. (2020). Outcomes of repeat left ventricular assist device exchange. ASAIO J 66, 64–68. https://doi.org/10.1097/MAT.0000000000000928.
Hinds, E. D., Marin, M. J., George, J. et al. (2019). A coronary cameral fistula treated with coil embolization. JRSM Cardiovasc Dis 8, 2048004019856801. https://doi.org/10.1177/2048004019856801.
Anjum, A., Kurihara, C., Critsinelis, A. et al. (2018). Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs 21, 285–292. https://doi.org/10.1007/s10047-018-1047-0.
Gohar, S., Sheth, S. and Delgado, R., III (2017). Optimization of right ventricular function preoperatively for LVAD implantation. In Mechanical Circulatory Support for Advanced Heart Failure: A Texas Heart Institute/Baylor College of Medicine Approach (35–55). https://doi.org/10.1007/978-3-319-65364-8_3.
Jabbar, A. A., Franklin, W. J., Simpson, L. et al. (2015). Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J 42, 40–43. https://doi.org/10.14503/THIJ-13-3374.